Viruses are microscopic organisms which are contagious agents that reproduce only inside the living cells of other organism. Viruses can infect all types of life forms right from a bacterium to archaea and also animals and plants to microorganisms. Viruses are not alive. They do not have the ability to grow or multiply on their own and require to go into an animal or human cell and multiply with the help of the host organism they live enter in. Viruses also have the ability of infect bacterial cells.
The mechanism used by viruses is that the virions that is the virus particles attack the cell and capture the machinery to bring out their multiplication and growth. The infected cell then produces viral particles instead of its regular products.
The evaluation of the virology safety of a product and the capability of an engineering process to form a product which is harmless and risk-free for human use is a fundamental measure during the development of a biological product. To achieve these criteria, there is a need to perform viral safety assays and subsequently to conduct viral clearance in the course of product development.
The factors that propel the growth of the global virus clearance market include a strong pharmaceutical product pipeline that will benefit in the development of the pharmaceutical and biotechnology industry, the rising government funding for the pharmaceutical and biotechnology industries, innovation of novel drugs, and rise in R&D activities. Additionally, the increased emphasis on quality assurance and quality control departments in the industries boost the growth of the global virus clearance market.
On the other hand, there are also factors that hamper the growth of the global virus clearance market like the high degree of consolidation act.
The global virus clearance market is classified on the basis of application, method, end users and geography.
On the basis of application, the global virus clearance market is classified as Blood & Blood Products, Cellular & Gene Therapy Products, Tissue & Tissue Products, Vaccines and Therapeutics and Stem Cell Products. Amongst the application sector the Vaccines and Therapeutics account for the highest share of the of the global virus clearance market.
On the basis of method, the global virus clearance market is classified as Viral Detection Method, Viral Inactivation Method and Viral Removal Method. In 2015, the Viral Detection Method holds for the major share of the global virus clearance market.
On the basis of end-users, the global virus clearance market is classified as Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Other End Users. The other end users consist of medical device companies, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, cell banks, small cell culture laboratories and consultants,and media/sera manufacturers.
On the basis of geography, the global virus clearance market is classified as North America, Europe, Asia and Rest of the World. North America sector is further sub classified into U.S. and Canada.
Some of the prominent players that fuel the growth of the global virus clearance market include Charles River Laboratories International, Inc., Lonza Group, Merck KGaA, Sigma-Aldrich Corporation, Avance Biosciences Inc., BSL BIOSERVICE, Clean Cells, SGS S.A., Texcell, Inc., and WuXi PharmaTech Inc.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."